Tin tức & Cập nhật

Use of molnupiravir or nirmatrelvir/ritonavir in high-risk patients with mild-to-moderate COVID-19 is associated with reduced in-hospital mortality, reduced hospital admissions or readmissions, and potential healthcare cost savings, according to a real-world retrospective cohort study led by researchers from the Chinese University of Hong Kong and the University of Hong Kong.

Hospitals with higher staffing see lower rates of mortality among COVID-19 inpatients, a recent study has found.

Predicting which newborn will go on to develop atopic dermatitis (AD) and how severe it will be is now feasible, according to the BABY* study.

Dropping animal protein for plant proteins in the dietary approaches to stop hypertension (DASH) diet appears to have favourable effects on cardiometabolic risk factors in patients with obesity and metabolic syndrome, according to a double-blind randomized controlled clinical trial.

COVID-19 patients with chronic statin exposure appear to be at lower risk of developing acute kidney injury (AKI) during hospitalization in addition to having reduced levels of inflammation, as reported in a study.

Treatment with the nucleos(t)ide analogue (NUC) tenofovir alafenamide (TAF) for 2 years leads to improvements in liver stiffness among patients with chronic hepatitis B (CHB), including those with advanced liver fibrosis, according to a study presented at the IDWeek 2022 in Washington, DC, US.

Drinking 2–3 cups of coffee – be it ground, instant, or decaffeinated – daily is consistently associated with significant reductions in the risks of cardiovascular disease (CVD), coronary heart disease (CHD), congestive cardiac failure (CCF), and all-cause mortality in a new analysis of the UK Biobank study.

Olfactory and gustatory** loss/alterations are common COVID-19 symptoms, but recovery is expected in most patients within the first 3 months. However, these dysfunctions may persist in some individuals, according to a reconstructed meta-analysis from Singapore.